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Background: Positional stability of the endograft is essential for long-term durability after endovascular abdominal aortic
aneurysm repair (EAR). However, the cumulative risk of delayed endograft migration has been sparsely reported.
Method: A total of 91 patients studied underwent EAR with the AneuRx endograft with a minimum 1 year from
implantation. Data from a prospective database were assessed for proximal endograft migration, defined as >5 mm
change from the initial endograft position. Multiple anatomic characteristics were also examined. Sixty-nine patients were
alive, with complete follow-up at 1 year, with a mean time from implantation of 33.2  1.1 months. Data are mean 
SEM.
Results: Endograft migration occurred in 15 patients, giving a cumulative event rate of 7.2% (5/69) at 1 year, 20.4%
(10/49) at 2 years, 42.1% (8/19) at 3 years, and 66.7% (2/3) at 4 years post-EAR (P  .01). Although the initial aortic
neck diameter did not differ between the groups (21.5  0.6 mm vs 21.8  0.3 mm, P  .61), significant (P <.05), late
aortic neck enlargement was seen in patients with migration (25.0 1.6 mm, 26.2 1.2 mm, and 27.0 1.0 mm at 1,2,
and 3 years, respectively) but not in nonmigrators. Regression analysis demonstrated a statistically significant (P < .05)
correlation between endograft oversizing and late aortic neck dilation. Overall migration risk was 29.2% in patients
oversized >20% and 18.6% in patients oversized<20%. Aortic neck angulation (23.4 6.6 degrees vs 23.5 3.3 degrees,
P  .99), aortic neck length (25.9  2.5 mm vs 27.0  1.6 mm, P  .74), initial endograft/aortic neck overlap (18.6 
2.6 mm vs 19.4 1.4 mm, P .80) and size of abdominal aortic aneurysm (55.5 1.5 mm vs 54.9 1.4 mm, P .84)
were similar between migrators and nonmigrators, respectively. Secondary endovascular treatment with aortic cuffs was
required in five patients with device migration.
Conclusions: Device migration after EAR with the AneuRx endograft occurred with significant frequency, the incidence
of which increased with the length of follow-up. Late aortic neck dilation was significantly associated with migration.
Oversizing of the endograft of >20% may accelerate this late aortic neck dilation. However, the etiologies of endograft
migration were likely multifactorial, as the majority (8/15) of patients experiencing migration were oversized <20%.
Although endovascular repair of these migrations is usually possible, the long-term durability of these secondary
procedures is unknown. Careful surveillance for this endograft failure mode must be an essential component of post-EAR
follow-up. (J Vasc Surg 2002;36:476-84.)
Endovascular repair of infrarenal abdominal aortic an-
eurysms (AAAs) has grown rapidly since Parodi reported
the first case over a decade ago.1 Although initial proto-
types had fairly high early failure rates,2 second- and third-
generation endografts have demonstrated excellent short-
term results.3,4 As such, the quest for long-term durability
is now becoming the holy grail of endovascular aneurysm
repair (EAR).
Midterm reports of EAR have generally sounded a
cautionary note, demonstrating a significant incidence of
late problems that require intervention.5,6 Failure modes
after EAR have included modular component separa-
tion,7,8 stent and/or hook fractures,9 fabric erosion,10 and
“micro leaks” presumably causing endotension and aneu-
rysm expansion.11 Because positional stability of the en-
dograft is essential for long-term durability, proximal en-
dograft migration is another important potential failure
mode (Figs 1 A, B, and C). In order for EAR to challenge
open AAA repair in patients who have a long life expect-
ancy, these failure modes must be identified and mini-
mized. The purpose of our study was to examine the
incidence and risk factors for one particular failure mode,
that of proximal endograft migration.
METHODS
From September 1997 to December 2000, 94 patients
with infrarenal AAAs were evaluated and scheduled for
repair with an AneuRx endograft (Medtronics/AVE Inc,
Sunnyvale, Calif) at the Ochsner Clinic Foundation Hos-
pital. Preoperative contrast-enhanced computed tomo-
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graphic (CT) scanning and selective use of arteriograms
were employed to select individuals with appropriate anat-
omy. The majority of patients were enrolled in phase II/III
US Food and Drug Administration (FDA) trials and thus
met those inclusion criteria.3 Specific details regarding our
operative team, experience with intraoperative imaging,
and preference towards regional anesthesia have been pub-
lished previously.12 Postoperative follow-up consisted of a
1 to 2 week, 1-month, 6-month, 12-month and then yearly
clinic visit unless indications demanded more frequent at-
tention. Radiographic surveillance included a contrast-en-
hanced CT scan (2.5-mm axial images) and plain abdomi-
nal radiographs at each follow-up visit. Surveillance
imaging of individuals who elected to have follow-up else-
where was requested from the primary physician. Anatomic
and outcome data from each follow-up visit were collected
and recorded in our vascular section database. Query of this
prospectively maintained database supplemented with a
retrospective review of medical records was performed to
retrieve all patient demographics, anatomic characteristics,
and outcome data.
Definitions. Endograft migration was detected on
axial CT scans by identifying changes in graft positioning in
relation to the lowest renal artery. Specifically, the distance
from the inferior aspect of the most caudad renal artery to
the first axial cut with any appreciable endograft was mea-
sured. In accordance with the Lifeline Registry guidelines,
migration was considered to be movement of the endograft
5mm.13 Changes in neck diameter were detected by
comparing follow-up CT images to the preoperative scan.
Aortic neck diameter was measured from the external edges
(adventitia-to-adventitia) by using manual calipers. All an-
atomic measurements were made from hard copy films. In
a minority of cases, an accurate preoperative record was
unavailable so the initial postoperative CT scan was used as
the baseline (n  4). Postoperative aortic neck diameters
were measured at the first image that contained a portion of
the endograft. In patients who experienced endograft mi-
gration, comparisons were made to postoperative scans to
identify the original level of the endograft for subsequent
neck diameter measurements. To avoid false measurements
related to neck angulation, minor axis diameters were used.
Measurement of the angle between the infrarenal aortic
neck and the longitudinal axis of the aneurysm was mea-
sured with a protractor from either angiograms or three-
dimensional CT reconstructions.12 Overlap of the aortic
neck by the endograft was calculated by subtracting the
initial postoperative neck length (distance measured on CT
Fig 1. A, Postoperative plain abdominal radiograph demonstrat-
ing endograft position at the L1-L2 level (arrow). B, Plain abdom-
inal radiograph demonstrating endograft position at the L1-L2
level (arrow) 1-year post implantation. C, Plain abdominal radio-
graph demonstrating endograft position at the L2-L3 level (arrow)
2 years post implantation.
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scan from the lowest renal artery to the endograft) from the
preoperative aneurysm neck length. Percentage of en-
dograft over-sizing was calculated by the following for-
mula: ([endograft diameter/aortic neck diameter]-1) 
100. The attending surgeon reviewed all images at the time
of follow up.
Patients were evaluated for endograft migration at 1, 2,
3, and 4 years post endograft implantation. To assess for
temporally related risk factors for migration, subgroup
analyses were performed on patients stratified to four dif-
ferent categories on the basis of time from implantation. To
avoid confounding variables, any individual experiencing
migration was excluded from further subgroup analysis
after the event date. However, patients who migrated ear-
lier (ie, at 1 or 2 years) but had follow-up at a later date (ie,
at 3 years) were included in calculations of cumulative risk
of migration.
Statistics. Cumulative risk of endograft migration was
assessed by use of 2 analysis. Differences in patient age,
aneurysm size, aortic neck diameter, neck length, and neck
angulation, endograft oversize, and endograft/aortic neck
overlap were tested for significance by using two-tailed t
tests. Bivariate and linear regression analyses were used to
test for relationships between endograft over-sizing and
changes in aortic neck diameter. Correlations between
degree of over-sizing and late aortic neck dilation were
tested with a one-way analysis of variance (ANOVA). Data
are presented as mean  standard error.
RESULTS
A total of 94 patients were studied in an intent-to-treat
protocol. AneuRx modular bifurcated endografts were suc-
cessfully implanted in 91 (96.8%) patients; three (3.2%)
patients underwent conversion to an open repair. Five
patients who were undergoing successful deployment of
endografts were treated with the early “stiff-body” proto-
type. The average patient age was 72.6 years, and the mean
aneurysm size was 55.0  1.1 mm. Of the 89 patients, 81
(88%) of the patients were male and 11 (12%) were female.
Of the 91 patients with successful deployments, 10 died
within the first year, leaving an initial cohort of 81 patients
with a minimum of 1-year follow-up. The causes of death
within the first year were cardiac (n  4), respiratory (n 
2), cancer (n 2), and unknown (n 2). Details regarding
exclusion of additional patients during each follow-up pe-
riod are presented in Table I. A total of 69 patients were
available for analysis, with a mean time from implantation
of 33.2  1.1 months.
Endograft migration. A total of 15 patients were
found to have endograft migration of5 mm. One of these
patients had been treated with the “stiff-body” device,
whereas the remaining 14 were treated with the currently
available AneuRx device. The mean migration distance was
8.8  1.0 mm (range, 5-15 mm). The risk of migration
increased with the length of follow-up (Fig 2). Cumulative
endograft migration rate was 7.2% (5/69), 20.4% (10/49),
42.1% (8/19), and 66.7% (2/3) at 1, 2, 3, and 4 years post
implantation, respectively (P  .01). New episodes of
migration were seen during each subsequent year of follow-
up. Five patients experienced migration within the first year
of follow-up, six within the second year, three in the third
year, and one in the fourth year.
Five patients with migration underwent treatment, all
with placement of proximal aortic cuffs. Two of these
patients had developed type I proximal endoleaks, one of
whom experienced rapid aneurysm enlargement (15 mm
over 6 months). Patients treated for migration had an
average migration distance of 13.3  1.8 mm. The ten
remaining patients migrated an average of 7.0  0.6 mm
and are currently being managed by close observation.
Anatomic characteristics of all patient cohorts are pre-
sented in Table II. There was a trend towards greater
endograft over-sizing in migrators (23.5 3.6% vs 18.2
1.4%) that did not achieve statistical significance (P .11).
Size of AAA, aortic neck length and diameter, aortic neck
angulation, and endograft-aortic neck overlap were similar
between the two groups. Subgroup analysis of migrators at
1 year (Table III), however, demonstrated a trend towards
shorter endograft overlap (12.3  4.3 mm vs 19.7  1.2
mm, P .12). Migrators at years 2 and 3 (Tables IV and V)
had no significant differences or trends in endograft overlap
when compared to nonmigrators.
Aortic neck dilation. Aortic neck dilation during fol-
low up differed significantly between groups (Fig 3). Al-
though preoperative neck diameters were not different,
Fig 2. Cumulative risk of endograft migration.
Table I. Patient cohort stratified by year from
implantation
Years of follow-up 1 2 3 4
Initial patient cohort 91 70 34 6
Exclusions
Death 10 10 6 1
Delayed conversion* 0 2 1 0
Incomplete data 12 9 8 2
Final patient cohort 69 49 19 3
*Total delayed conversions equal 2; one patient suffered a rupture and one
had a persistent endoleak with aneurysm expansion.
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migrators at 1 year had significantly larger neck diameters
(25.0 1.6 mm) than did nonmigrators (22.6 0.3 mm),
P .05. This significant difference continued in follow-up
of patients at 2 and 3 years. It is of interest that individuals
who migrated within the second year demonstrated no
difference in aortic neck size at 1 year when compared to
nonmigrators.
Bivariate analysis demonstrated a highly significant cor-
relation between endograft over-sizing and aortic neck
dilation at 1 and 2-years post implantation (P  .05). Figs
4 and 5 are linear regression plots demonstrating the rela-
tionship of endograft over-sizing and aortic neck dilation.
Patients with 20% over-sizing had significantly greater
late changes in aortic neck diameter when compared to
those with 20% (Fig 6). When patients were categorized
by percentage of endograft over-sizing, eight were over-
sized 20% and seven by 20%. Observed migration
within these categories of over-sizing was 18.6% and 29.2%,
respectively.
DISCUSSION
Endovascular aneurysm repair has proven to be a reli-
able alternative for patients with extensive comorbid illness,
Table II. Anatomic characteristics independent of time from implantation
Characteristic
Overall
(n  69)
Migrators
(n  15)
Nonmigrators
(n  54) P
M:F (n) 12.8:1 6.5:1 17:1 NA
Age (y) 72.6  0.7 71.3  1.5 73.0  0.8 .33
Aneurysm size (mm) 55.0  1.1 55.5  1.5 54.9  1.4 .84
Preoperative neck diameter (mm) 21.7  0.3 21.5  0.6 21.8  0.3 .61
Graft oversize (%) 19.5  1.4 23.5  3.6 18.2  1.4 .11
Preoperative neck length (mm) 26.7  1.3 25.9  2.5 27.0  1.6 .74
Graft overlap (mm) 19.2  1.2 18.6  2.6 19.4  1.4 .80
Neck angulation (degree) 23.5  2.9 23.4  6.6 23.5  3.3 .99
Data are mean  SE.
Table III. Aneurysm characteristics 1-year post
implantation
Characteristic
Migrators
(n  5)
Nonmigrators
(n  64) P
Aneurysm size 54.4  2.5 55.1  1.2 .88
Preop neck diameter 21.8  1.4 21.7  0.3 .94
Graft oversize (%) 20.4  5.8 19.4  1.4 .84
Preop neck length 27.2  5.4 26.7  1.4 .92
Graft overlap 12.3  4.3 19.7  1.2 .12
Neck angulation (degree) 27.5  13.0 23.2  3.0 .71
Neck diameter (1 y) 25.0  1.6 22.6  0.3 .05*
Neck change (1 y) 2.8  1.8 0.6  0.3 .08
*Statistically significant. Data are mean SE. Data are in millimeters unless
otherwise indicated.
Table IV. Aneurysm characteristics 2 years
post-implantation
Characteristic
Migrators
(n  6)
Nonmigrators
(n  39) P
AAA Size 57.5  2.8 54.1  1.5 .39
Preop neck diameter 21.0  1.1 21.5  0.3 .58
Graft oversize 27.0  6.9 19.8  1.7 .16
Preop neck length 22.0  3.8 27.7  1.8 .25
Graft overlap 17.7  2.7 19.6  1.7 .66
Neck angulation (degree) 25.7  10.1 20.9  3.7 .62
Neck diameter (2 y) 26.2  1.2 22.7  0.4 .05*
Neck change (2 y) 4.8  1.7 1.3  0.4 .05*
Data excludes four patients who migrated within the first year post implan-
tation. Data are mean  SE. Data are in millimeters unless otherwise
indicated.
*Statistically significant.
Table V. Aneurysm characteristic 3 years post
implantation
Characteristic
Migrators
(n  3)
Nonmigrations
(n  11) P
AAA size 52.7  2.7 51.7  3.4 .89
Preop neck diameter 21.3  0.7 20.5  0.8 .56
Graft oversize (%) 28.2  1.0 18.6  3.9 .24
Preop neck length 29.3  5.0 26.5  2.9 .65
Graft overlap 24.3  7.4 18.3  2.4 .32
Neck angulation (degree) 8.5  8.5 31.0  8.1 .25
Neck diameter (3 y) 27.0  1.0 22.4  0.7 .05*
Neck change (3 y) 5.7  0.9 2.1  0.9 .07
*Statistically significant.
Data excludes five patients who migrated within the first 2 years post
implantation. Data are mean SE. Data are in millimeters unless otherwise
indicated.
Fig 3. Changes in aortic neck diameter over time in patients with
and without endograft migration.
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which is believed to preclude them from a conventional
aneurysm repair. High rates of successful implantation as
well as reductions in blood loss, length of hospital stay, and
rates of subsequent aneurysm rupture in the short- to
midterm make this procedure ideal for patients with limited
life expectancies. Chuter et al14 demonstrated this advan-
tage in a group of high-risk patients by achieving a 1.7%
perioperative mortality rate in a patient cohort that exhib-
ited 81%, 34%, and 49% rates of coronary insufficiency,
congestive heart failure, and chronic obstructive pulmonary
disease, respectively. Bush and colleagues4 offered another
example of success in this high-risk population when they
found comparable success rates at 2 years in patients strat-
ified as either low-risk or increased-risk for intervention
based on preexisting medical conditions. Reports such as
these have paved the way for acceptance of this technique in
the high-risk patient. However, as Bush et al caution in
closing remarks “advocating endovascular treatment for
the patient who is at low risk for the standard operative
intervention remains problematic.” The reason for such a
warning is based on the fact that the long-term durability of
these devices is unknown.
Early problems related to endograft design led to struc-
tural modifications that improved success rates, but recent
reports of mid- to long-term failures have raised questions
regarding endograft durability. Ho¨lzenbein et al6 reported
a prospective follow up analysis of 173 patients with a
midterm reintervention rate of 26.6%; 46% of the reinter-
ventions were required within the first year and 74% were
required within the second year, suggesting a possible
long-term durability problem.
Although a reduction in reinterventions was experi-
enced with second-generation endografts, no comparison
was made among different endograft designs. Currently
there are a number of different endograft designs that vary
in method of attachment, metallic composition, and mod-
ular component structure. If valid arguments are to be
entertained regarding the long-term durability of particular
endografts, focused studies looking for causes of failure
need to be conducted and must be endograft specific.
In our analysis of 91 patients with the AneuRx en-
dograft, a significant rate of distal migration was observed
that increased over time and did not appear to plateau.
Upon evaluation of migration from a temporal standpoint,
we determined that our patients experienced event rates of
7.2%, 20.4%, 42.1%, and 66.7% at 1 year, 2 years, 3 years,
and 4 years post implantation. Because of the very small
number of patients available for 4-year review (n  3), the
risk of migration at this long-term time-point must be
considered preliminary. Further long-term follow up with
larger cohorts of patients will be needed to assess whether a
plateau in the incidence of this failure mode occurs.
Endograft migration with the AneuRx device has been
reported previously. In the seminal report of multicenter
FDA trial data of this device by Zarins et al,3 6.1% (2/33) of
patients experienced migration of the proximal endograft at
1 year, similar to our 1-year migration rate of 7.2%. Cao and
colleagues15 reviewed 113 patients with a minimum of 2
years follow-up after EAR with the AneuRx device. In this
study, 10 mm was employed as the minimum distance to
Fig 4. Correlation of over-sizing and neck diameter change 1
year post implantation.
Fig 5. Correlation of over-sizing and neck diameter change 2
years post implantation.
Fig 6. Effect of endograft oversizing on changes in aortic neck
diameter over time.
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define migration. A total of 17 patients (15%) had en-
dograft migration with use of this strict definition, giving an
event rate of approximately 20% at 24 months and 27% at
36 months by life-table analysis. These late rates of en-
dograft migration were similar to those found in the
present study.
Measurement of migration. Evidence of migration
in this study was quantified by measuring the distance from
the lowest renal artery to the top of the endograft from axial
2.5-mm cuts of CT scans. In patients with significant neck
angulation, this method likely underestimated true length
of device migration. This fact may help explain why aortic
neck angulation was not higher in the migrator group.
Although the maximum migration distance reported by
axial CT measurement in this study was 15 mm, examina-
tion of plain radiographs in some patients (Fig 1, A-C)
suggested that the true migration distance was significantly
longer. However, we could not accurately quantify such
measurements from plain abdominal radiographs. Mea-
surement of true center-line lengths with multiplanar CT
reconstructions may provide more precise length measure-
ments.16
Treatment of migration. Treatment of endograft mi-
gration has been addressed primarily with the addition of
aortic cuff(s). In the study of Cao et al,15 patients with
endograft migration had placement of aortic cuffs in six
patients and open conversion in two patients. In a report
from the Stanford group, Lee et al17 examined 67 patients
treated with the AneuRx endograft with a minimum of
1-year follow-up (mean, 18 months). In this patient co-
hort, seven (10.4%) were treated for migration with aortic
cuffs. No estimation of an overall (including untreated)
migration rate was made. In the current study, five patients
(7.2%) were treated with placement of aortic cuffs.
Although treatment of these proximal migrations with
aortic cuffs is usually possible, the secondary durability of
this approach is unknown. It is possible that continued
downward migration of the main device could continue,
causing component separation. There are at least 10 re-
ported cases of AneuRx main body separation from aortic
cuff(s) that were placed at the initial implant.7,8,16-18 These
component separations occurred 1 to 3 years after implan-
tation. Although firm treatment recommendations cannot
be made on the basis of such anecdotal data, patients
treated for migration with aortic cuffs warrant very close
observation for further migration and/or component sep-
aration. In such instances, plain radiographs may be more
sensitive in detecting component separation that CT scan-
ning.7
Migration risk factors. Risk factors for endograft mi-
gration were found by Cao et al15 to be an initial aortic neck
diameter of 25 mm, preoperative AAA size of 55 mm,
and aortic neck enlargement of 10%. We did not find
significant differences in either initial neck diameters or
AAA size between migrators and nonmigrators. However,
our data agreed with the finding that migrators had signif-
icant dilation of the aortic neck.
The etiology of endograft migration in dilating aortic
necks is intuitive, relating to the loss of friction seal as the
neck enlarges. However, the underlying reason(s) for aortic
neck dilation is uncertain. Reports on changes in neck size
after EAR have been conflicting.19-20 In this current study,
there was a significant relationship between degree of en-
dograft over-sizing and subsequent aortic neck dilation.
There is a plausible explanation for this relationship. The
AneuRx endograft uses radial force to create wall friction
that contributes to stability of the endograft within the
aorta. This radial force exerts a constant outward pressure
on the aortic wall. Over time this constant outward force
may exhaust the elastic recoil of the degenerating aortic
wall and result in enlargement of the aneurysm neck. As the
aneurysm neck dilates, the endograft approaches its maxi-
mal diameter. This in turn translates into a reduction in
outward force and ultimately a reduction in the friction that
maintains the endograft in position. By excessive over-
sizing (20%), the aneurysm neck is exposed to a higher
radial force generated by the larger endograft. This may
accelerate the natural phenomenon of aneurysm neck dila-
tion.
The decision to oversize the endograft by more than
20% was typically based on the presence of short and/or
angulated aortic necks. We felt that the additional radial
force might be beneficial with unfavorable aortic neck
anatomy. Criado et al21 have also reported routine oversiz-
ing of 20% in patients with challenging neck anatomy.
Our long term data, however, suggest that this practice may
be counterproductive.
It is important to underscore that the majority (8/15)
of migrators were not oversized 20%. The causes of
endograft migration are likely multifactorial and are not
solely a consequence of generous over-sizing. In the sub-
group analyses of patients who had migrated by their 1-year
follow up, there was a trend toward a shorter initial en-
dograft–aortic neck overlap. This decreased overlap could
have contributed to early (1 year) migration. No such trend
was seen with later migrators, however.
What design features might minimize endograft migra-
tion? It was hypothesized that the columnar rigidity pro-
vided by fully supported endografts like AneuRx might
prevent migration,22 but our data and those of others have
not found this to be the case. Experimental studies have
demonstrated that the addition of barbs and/or hooks to
the proximal endograft can significantly increase the dis-
placement force required for endograft migration.23 A
self-expanding endograft with a friction seal only required
2.5 N for displacement, but a device with hooks and barbs
required 22.5 N. Early clinical prototypes, mostly with the
Ivancev-Malmo stent-graft system, had an unacceptable
migration risk despite hooks and barbs.24 However, other
endograft designs with hook fixation have shown minimal
migration.25
Surveillance and treatment recommendations. On
the basis of the findings of this study, the following recom-
mendations can be made. (1) The distance between the
lowest renal artery and the endograft should be prospec-
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tively recorded from every CT scan and compared to the
prior study. Patients with evidence of migration should
have more frequent subsequent surveillance. (2) Aortic
neck diameter should also be routinely measured in follow-
up, and if dilation is seen, more frequent CT surveillance
should be instituted, as these patients are at significantly
elevated risk of subsequent migration. (3) Prophylactic
therapy for significant endograft migration should be con-
sidered if the remaining endograft–aortic neck overlap is
5 to 10 mm. With further migration, these patients are at
increased risk of acute repressurization of the aneurysm sac
that could present as a symptomatic or ruptured aneurysm.
(4) Patients treated for migration with aortic cuffs should
undergo CT and plain radiograph surveillance at a mini-
mum of every 6 months.
CONCLUSIONS
There was a significant risk of endograft migration after
EAR with the AneuRx device, the incidence of which
increased with time and did not appear to plateau. Late
aortic neck dilation was correlated highly with device mi-
gration. Over-sizing of the endograft by20% significantly
increased the risk of late aortic neck dilation. Excessive
radial forces associated with endograft over-sizing may
contribute to proximal aneurysm neck dilation and subse-
quent endograft migration. However, it is doubtful that a
single factor is responsible for endograft migration; the
majority of patients who experience migration in this series
were oversized by 20%. Although endovascular repair of
endograft migration is usually possible, the long-term du-
rability of these secondary procedures is unknown. Careful
surveillance for this endograft failure mode must be an
essential component of post-EAR follow-up.
We thank Richard Chambers, MSPH, for performing
the statistical analysis for this study.
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DISCUSSION
Dr L. Stevens (Knoxville, Tenn). Drs. Conners, Sternbergh,
Money, and group presented the Ochsner Clinic experience with
endograft migration and send a cautionary note. Ninety-four
patients are analyzed between 1 and 4 years following endograft
placement. Cumulative yearly migration rates of 7%, 20%, 42%, and
67% are reported. In this series, aortic neck angulation, aortic neck
length, initial endograft-to-aortic neck overlap, and aneurysm sac
size do not predict migration with statistical confidence. This study
does, however, determine generous oversizing as a predictor of
graft migration and notes dilating necks in migrating aneurysms.
This presentation is timely and presses critical issues in aortic
endografting. In this arena it is all about outcomes. Specifically
targeted are effectiveness, durability, and mechanisms of graft
failure. Quantum advance in device design coupled with unforgiv-
ing technical learning curves makes tracking outcomes critical yet
challenging. This moving-target technology is evidenced by widely
varying results according to series, device, and surgeon experience.
In a multicenter phase-II FDA trial using the same AneuRx device,
there was a 1.7% incidence of migration as measured by the core
laboratory. Of these seven, none ruptured, none required conver-
sion, three had no enlargement, and three were treated with
secondary cuff placement. In a single-center experience of 128
AneuRx Dr Mall reports a 4.7% incidence of graft migration.
Again, in this series there were no ruptures, no migrations requir-
ing open conversion, and only three required cuff repair. Predic-
tion of poor outcomes and migration is not device specific. Studies
on Ancure, on Zenith by Brown, and on AneuRx by Fillinger all
identify aortic neck angulation as a predictor of poor outcomes.
Today’s presentation shows no statistically significant impact of
neck angulation on migration; however, this same Ochsner group
recently presented and published in Journal of Vascular Surgery
online that neck angulation is a predictor of poor outcomes includ-
ing death, open conversion, aneurysm expansion, type-I endoleak,
and graft migration. Certainly it is important to be cautious.
Physicians are learning from early experience, clinical trials, and
critical outcomes assessment as presented by these pioneering
endovascular surgeons today. I find the outcomes literature for
endovascular grafting encouraging and claim that most adverse
events are predictable by anatomic criteria and preventable by
meticulous planning, patient selection, and technical expertise. At
the University of Tennessee in Knoxville, our experience in the
research lab and the clinic highlights the importance of placing the
graft in healthy vessel segments proximally near the renal arteries
and distally well into the iliacs near the iliac bifurcation to secure
graft fixation. I would like to congratulate the authors and have
four questions for Dr. Sternbergh. First, what do you think is the
clinical significance of graft migration? Have you had any ruptures
in this series? Have you had to convert any to open for migration?
Second, with results you reported here today, are you still implant-
ing the AneuRx device, and, if so, why? Third, do you consider a
hostile aortic neck, one with calcifications, mural thrombus, and
angulation a risk factor for migration? And last, what planning
considerations and technical maneuvers do you perform to prevent
graft migration? Thank you.
Dr Sternbergh. (New Orleans, La). Thank you for those
comments. Let me start at the top of your questions.
One, what is the clinical significance of this? I think that it is
very clinically significant if grafts are migrating. We can only have a
long-term durable result if the endograft stays where you have
placed it. If it migrates significantly, the ultimate end-result can be
a catastrophic loss of seal, causing type-I endoleak aneurysm ex-
pansion, and in the worst case scenario, rupture. In our group of 15
patients in whom we have seen migration of 5 mm or greater, five
of those have undergone treatment for this migration. Those have
all been done with aortic cuffs. Two of those patients had devel-
oped type I leaks and one had developed a large expanding
aneurysm. We have not had any ruptures in those patients who
have migrated. We have had one rupture in our entire series of
AneuRx patients, and this was a patient that had a known type-I
leak who refused any follow-up and perhaps not surprisingly went
on to rupture. That was not associated with migration.
Although we have only treated five of these 15 patients with
migration, there are at least one or two patients who are probably
going to require an open conversion because of device kinking,
which may make an endovascular repair difficult.
Secondly you asked, are we still using this device? In the last 2
years we have been involved with clinical trials of next-generation
devices, and the large majority (80%) of our experience in the last
2 years has been with other devices. However, we still are selec-
tively using this endograft in patients with very favorable anatomy
who are poor candidates for open repair.
Your third question was about hostile necks, and I think that is
a very important question. As you pointed out, data that was
presented at the SVS last summer by our group suggested a
significant correlation of adverse neck anatomy, particularly neck
angulation with late problems including migration (Sternbergh et
al, J Vasc Surg 2002;35:482-6). It was very much to my surprise
that when we accumulated an additional 10 people who migrated,
the significance of aortic neck angulation fell out completely. Our
data showed really no trends at all in those who migrated vs those
who did not migrate in terms of neck angulation. Does that mean
that I think we should be treating highly angulated necks? Abso-
lutely not, and I still think that that is a very significant risk factor
for a whole host of problems probably including migration, al-
though our expanded data with more follow-up do not support that.
Dr Francis Robicsek (Charlotte, NC). It is a very interesting
study and most probably whatever you said is appropriate, but I
have some remarks regarding the methods. You related the neck of
the graft to neighboring anatomic structures; however, the aorta
may get longer and the spinal column may get shorter in this
patient population. We tried to use a similar method when we
worked on a study of elongation of Dacron grafts, and we found it
somewhat unreliable. You are counting in millimeters. Wouldn’t it
be a much better method that when you put in the graft somehow
to place some separate markers? I am not sure you can do it if you
do not operate, but I call your attention. There is a potential fault
with the method of relating to neighboring structures because
everything moves there. The aorta can bend, may get longer, and
unfortunately with advancing age the spinal column maybe gets
shorter, and these may influence the measurements.
Dr Sternbergh. Thank you for your questions. All of our
measurements were made in relation to the lowest renal artery. Our
CT scanning protocol typically uses 2.5-mm cuts. That is one of
the reasons we chose a 5-mm minimum to suggest that there really
was significant migration. As a corollary we have had at least two or
three patients who have migrated less than 5 mm by our measure-
ment, somewhere between 3 mm and 4 mm, who have developed
type I leaks and have required repair. They are not included in these
data because they did not migrate 5 mm but are still clinically
significant. I think that you can very accurately measure migration
based on CT scanning and I would encourage everyone in the
audience to make that a part of your usual surveillance. Frankly it
was not something that we looked for very closely early in our
experience. When we found people who had migrated at two years,
we went back and looked at their one-year scans, and if you looked
very closely, we found that there had been some migration that had
not been detected.
Dr Tim Sullivan (Greenville, SC). Chip, I really appreciate
you presenting this data. It may offer us some practical tips as to
who we should be selecting for endovascular repair because I think
that patient selection is key to long-term results.
The first question is, what is the maximum degree of neck
angulation that you will consider for a patient for endovascular
repair? The KUB that you presented, at least from back, here
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suggested that that patient did have a significant amount of angu-
lation. We have tended to be very conservative in treating patients,
with usually40 or 45 degrees of neck angulation for endovascu-
lar repair.
Second, I seem to recall that one of your coauthors suggested
in the past that the way to choose devices was to take careful
measurements and then to pick a 28 graft. (laughter) I wonder, has
this data changed your clinical practice in terms of oversizing?
Dr Sternbergh. Thank you for those questions, Tim. Our
data on neck angulation suggest that the risk of poor outcomes
increases significantly when you go beyond a 40-degree neck
angulation, and it increases radically once you go over 60 degrees.
I think that significant caution should be exercised in treating
anybody with a neck angulation greater than 40 degrees.
Your second question in terms of oversizing, I think you are
absolutely right. This was an unexpected finding when we were
looking at the data to find that there appears to be a correlation of
generous oversizing with late aortic neck dilation. Certainly on the
basis of these data I think it is very important not to oversize more
than 20%. One of the important take-home points, however, is that
the majority of the patients who migrated in this series were not
oversized more than 20%, so I think the reasons for migration are
not as simple as too much oversizing, but are most likely multifac-
torial.
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